← Leaderboards
Raj Kishore
Temple Univ Of The Commonwealth
$22,964,170
Attributed
$22,964,170
Total exposure
17
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.7M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,326,174 · 18
By mechanism
P01$24,077,851 · 10
R01$14,835,681 · 7
R21$412,642 · 1
Top collaborators
No co-investigators on record.
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Meghan C Brown$62,644
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsRepairedMediatingPhysiologicalMolecularInjuryIn VitroBone MarrowStem CellsCardiacSignal TransductionMyocardial IschemiaMicrornasMyocardialExosomeCell PhysiologyHeartHeart InjuriesHeart DiseasesTissuesMyocardial InfarctionPhenotypeAngiogenesisCardiac Repair
Grant awards (68)
Exosomes as mediators of cardiac injury and repair$2,379,218
P01 · FY2025 · HL · contact PI
MyomiR-499, Exosomes and Endothelial and Endothelial Progenitor Cells dysfunction in Diabetes$616,776
R01 · FY2025 · HL · contact PI
Project 1$515,125
P01 · FY2025 · HL · contact PI
Core B$374,193
P01 · FY2025 · HL · contact PI
Admin Core$63,400
P01 · FY2025 · HL · contact PI
Exosomes as mediators of cardiac injury and repair$2,393,843
P01 · FY2024 · HL · contact PI
MyomiR-499, Exosomes and Endothelial and Endothelial Progenitor Cells dysfunction in Diabetes$616,776
R01 · FY2024 · HL · contact PI
Project 1$515,125
P01 · FY2024 · HL · contact PI
Core B$388,818
P01 · FY2024 · HL · contact PI
Project 2: Gender Dimorphism in Bone Marrow Endothelial Progenitor Cell-mediated Post-Infarct Myocardial Repair$255,946
P01 · FY2024 · HL · contact PI
Admin Core$63,400
P01 · FY2024 · HL · contact PI
Restoration of myocardial reparative function of diabetic progenitor cells by epigenetic modulation$560,299
R01 · FY2023 · HL · contact PI
Project 2: Gender Dimorphism in Bone Marrow Endothelial Progenitor Cell-mediated Post-Infarct Myocardial Repair$435,875
P01 · FY2023 · HL · contact PI
Restoration of myocardial reparative function of diabetic progenitor cells by epigenetic modulation$560,299
R01 · FY2022 · HL · contact PI
Circular RNAs as novel mediators of cardiac repair$549,897
R01 · FY2022 · HL · contact PI
Project 2: Gender Dimorphism in Bone Marrow Endothelial Progenitor Cell-mediated Post-Infarct Myocardial Repair$435,875
P01 · FY2022 · HL · contact PI
Exosomes as mediators of cardiac injury and repair$2,249,182
P01 · FY2021 · HL · contact PI
Restoration of myocardial reparative function of diabetic progenitor cells by epigenetic modulation$560,299
R01 · FY2021 · HL · contact PI
Circular RNAs as novel mediators of cardiac repair$549,897
R01 · FY2021 · HL · contact PI
Project 2: Gender Dimorphism in Bone Marrow Endothelial Progenitor Cell-mediated Post-Infarct Myocardial Repair$435,875
P01 · FY2021 · HL · contact PI
Exosomes as mediators of cardiac injury and repair$2,288,095
P01 · FY2020 · HL · contact PI
Restoration of myocardial reparative function of diabetic progenitor cells by epigenetic modulation$560,299
R01 · FY2020 · HL · contact PI
Circular RNAs as novel mediators of cardiac repair$549,897
R01 · FY2020 · HL · contact PI
Functional characterization of Bone-Marrow EPC derived exosomes$457,230
P01 · FY2020 · HL · contact PI
Project 2: Gender Dimorphism in Bone Marrow Endothelial Progenitor Cell-mediated Post-Infarct Myocardial Repair$435,875
P01 · FY2020 · HL · contact PI
Exosome isolation and characterization$306,553
P01 · FY2020 · HL · contact PI
Administrative Core$82,276
P01 · FY2020 · HL · contact PI
Exosomes as mediators of cardiac injury and repair$2,325,872
P01 · FY2019 · HL · contact PI
Circular RNAs as novel mediators of cardiac repair$549,897
R01 · FY2019 · HL · contact PI
Functional characterization of Bone-Marrow EPC derived exosomes$466,125
P01 · FY2019 · HL · contact PI
Exosome isolation and characterization$310,139
P01 · FY2019 · HL · contact PI
Administrative Core$82,276
P01 · FY2019 · HL · contact PI
Exosomes as mediators of cardiac injury and repair$2,362,544
P01 · FY2018 · HL · contact PI
Functional characterization of Bone-Marrow EPC derived exosomes$474,712
P01 · FY2018 · HL · contact PI
Pluripotent cell-derived exosomes as mediators of myocardial regeneration$390,000
R01 · FY2018 · HL · contact PI
Exosome isolation and characterization$313,619
P01 · FY2018 · HL · contact PI
Administrative Core$82,277
P01 · FY2018 · HL · contact PI
Exosomes as mediators of cardiac injury and repair$2,363,250
P01 · FY2017 · HL · contact PI
Functional characterization of Bone-Marrow EPC derived exosomes$478,632
P01 · FY2017 · HL · contact PI
Pluripotent cell-derived exosomes as mediators of myocardial regeneration$390,000
R01 · FY2017 · HL · contact PI
Interleukin-10, stem cells and myocardial ischemia$390,000
R01 · FY2017 · HL · contact PI
Exosome isolation and characterization$278,975
P01 · FY2017 · HL · contact PI
Administrative Core$82,276
P01 · FY2017 · HL · contact PI
Interleukin-10, stem cells and myocardial ischemia$390,000
R01 · FY2016 · HL · contact PI
Pluripotent cell-derived exosomes as mediators of myocardial regeneration$390,000
R01 · FY2016 · HL · contact PI
Therapeutic Angiogenesis in Vascular Medicine IV$452,578
R01 · FY2015 · HL · contact PI
Pluripotent cell-derived exosomes as mediators of myocardial regeneration$390,000
R01 · FY2015 · HL · contact PI
Interleukin-10, stem cells and myocardial ischemia$384,150
R01 · FY2015 · HL · contact PI
Therapeutic Angiogenesis in Vascular Medicine IV$451,409
R01 · FY2014 · HL · contact PI
Interleukin-10, stem cells and myocardial ischemia$390,000
R01 · FY2014 · HL · contact PI
Effect of chronic alcohol on ischemic injury and endothelial cells$366,000
R01 · FY2014 · HL · contact PI
Effect of chronic alcohol on ischemic injury and endothelial cells$7,625
R01 · FY2014 · HL · contact PI
Therapeutic Angiogenesis in Vascular Medicine IV$439,101
R01 · FY2013 · HL · contact PI
Effect of chronic alcohol on ischemic injury and endothelial cells$362,950
R01 · FY2013 · HL · contact PI
Therapeutic Angiogenesis in Vascular Medicine IV$462,070
R01 · FY2012 · HL · contact PI
Effect of chronic alcohol on ischemic injury and endothelial cells$381,250
R01 · FY2012 · HL · contact PI
TNF mRNA stability and restenosis$377,438
R01 · FY2012 · HL · contact PI
Novel approaches to ischemic tissue repair$377,438
R01 · FY2012 · HL · contact PI
Therapeutic Angiogenesis in Vascular Medicine IV$463,086
R01 · FY2011 · HL · contact PI
Effect of chronic alcohol on ischemic injury and endothelial cells$381,250
R01 · FY2011 · HL · contact PI
Epigenetic Modulation of EPC for Cardiomyogenesis$381,250
P01 · FY2011 · HL · contact PI
TNF mRNA stability and restenosis$381,250
R01 · FY2011 · HL · contact PI
Novel approaches to ischemic tissue repair$381,250
R01 · FY2011 · HL · contact PI
TNF mRNA stability and restenosis$381,250
R01 · FY2010 · HL · contact PI
TNF mRNA stability and restenosis$381,250
R01 · FY2009 · HL · contact PI
Ethanol mediated endothelial injury and dysfunction$210,767
R21 · FY2007 · AA · contact PI
Ethanol mediated endothelial injury and dysfunction$129,795
R21 · FY2006 · AA · contact PI
Ethanol mediated endothelial injury and dysfunction$72,080
R21 · FY2006 · AA · contact PI